PolySea developers

PolySea is an Israeli biotechnology company specializing in the development of high-value biopolymers derived from red microalgae, specifically the Porphyridium species. The company utilizes a proprietary platform to extract and modify sulfated polysaccharides, which possess unique biological activities including anti-inflammatory, antioxidant, and antiviral properties. These seaweed-based polymers are designed for applications in advanced wound care, drug delivery systems, and specialized dermatological products. PolySea aims to replace synthetic and animal-derived ingredients with sustainable, marine-sourced alternatives that offer superior biocompatibility and functional performance. The company operates within the Israeli food-tech and bio-tech ecosystem, supported by prominent incubators and academic research.